Market News Today — AI-Curated Stock & Crypto Headlines

As Healthcare Rallies Is the Vanguard Health Care ETF of the Invesco Pharmaceuticals ETF the Better Fund for 2026?

PJP surged 45% in one year, but VHT's lower costs and higher dividend yield appeal to long-term income investors seeking …

Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?

IXJ offers broader diversification with 110 holdings and a lower 0.40% expense ratio, while PJP's concentrated U.S. pharma strategy delivered …

PJP vs. IYH: Which Healthcare ETF Is the Better Buy?

PJP delivered a higher return over the past year -- but IYH charges lower fees and pays a higher dividend …

Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026?

PJP delivers lower volatility and higher income with concentrated pharma exposure, while XBI offers broader biotech growth at lower cost.

Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026?

PJP delivered stronger 5-year returns with lower volatility, while FBT offers broader biotech exposure at a slightly cheaper cost.

IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?

Compare the portfolio concentration, risk profiles, and long-term growth of these two pharma ETFs.

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?

Compare portfolio concentration, risk profiles, and long-term growth as these two pharma ETFs take different approaches to capturing sector opportunity.